[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":613,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.47,"TPM_sd":15.51,"TPM_min":0.9,"TPM_25th_percentile":4.76,"TPM_median":9.39,"TPM_75th_percentile":21.18,"TPM_max":116.88},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":210,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.09,"TPM_sd":8.52,"TPM_min":2.02,"TPM_25th_percentile":6.14,"TPM_median":9.58,"TPM_75th_percentile":15.93,"TPM_max":61.16},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.05,"TPM_sd":3.83,"TPM_min":1.76,"TPM_25th_percentile":7.15,"TPM_median":8.42,"TPM_75th_percentile":11.64,"TPM_max":16.64},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":30,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.79,"TPM_sd":3.28,"TPM_min":1.73,"TPM_25th_percentile":4.66,"TPM_median":6.51,"TPM_75th_percentile":8.15,"TPM_max":15.37},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"Orphanet_178","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.92,"TPM_sd":1.04,"TPM_min":2.95,"TPM_25th_percentile":3.3,"TPM_median":3.7,"TPM_75th_percentile":4.31,"TPM_max":5.35},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.49,"TPM_sd":11.71,"TPM_min":3.63,"TPM_25th_percentile":5.98,"TPM_median":8.92,"TPM_75th_percentile":11.29,"TPM_max":48.01},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.97,"TPM_sd":1.76,"TPM_min":1.4,"TPM_25th_percentile":2.7,"TPM_median":3.55,"TPM_75th_percentile":4.94,"TPM_max":7.78},{"x_label":"Diffuse fibrillary astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse fibrillary astrocytoma","GTEx_tissue_subgroup":"","EFO":"Orphanet_251601","MONDO":"MONDO_0016688","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.33,"TPM_sd":3.66,"TPM_min":3.97,"TPM_25th_percentile":6.48,"TPM_median":10.77,"TPM_75th_percentile":12.04,"TPM_max":13.5},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.82,"TPM_sd":1.69,"TPM_min":4.44,"TPM_25th_percentile":5.35,"TPM_median":7.17,"TPM_75th_percentile":8.22,"TPM_max":9.05},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":72,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.29,"TPM_sd":8.63,"TPM_min":0.7,"TPM_25th_percentile":5.88,"TPM_median":8.97,"TPM_75th_percentile":11.35,"TPM_max":56.58},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.38,"TPM_sd":4.2,"TPM_min":2.9,"TPM_25th_percentile":7.29,"TPM_median":9.14,"TPM_75th_percentile":10.27,"TPM_max":23.68},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.7,"TPM_sd":3.99,"TPM_min":8.57,"TPM_25th_percentile":11.31,"TPM_median":11.78,"TPM_75th_percentile":12.39,"TPM_max":20.34},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":88,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.88,"TPM_sd":2.18,"TPM_min":0.29,"TPM_25th_percentile":4.4,"TPM_median":5.68,"TPM_75th_percentile":7.38,"TPM_max":12.41},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.56,"TPM_sd":2.76,"TPM_min":4.05,"TPM_25th_percentile":7.25,"TPM_median":9.22,"TPM_75th_percentile":10.52,"TPM_max":12.09},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.98,"TPM_sd":3.79,"TPM_min":1.87,"TPM_25th_percentile":5.12,"TPM_median":7.47,"TPM_75th_percentile":9.3,"TPM_max":17.71},{"x_label":"Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":19.3,"TPM_sd":9.34,"TPM_min":0.64,"TPM_25th_percentile":12.72,"TPM_median":18.34,"TPM_75th_percentile":21.64,"TPM_max":44.89},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.22,"TPM_sd":3.32,"TPM_min":2.85,"TPM_25th_percentile":6.36,"TPM_median":8.89,"TPM_75th_percentile":9.89,"TPM_max":12.59},{"x_label":"Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Hemangioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016748","MONDO":"MONDO_0016748","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.56,"TPM_sd":1.48,"TPM_min":3.06,"TPM_25th_percentile":3.83,"TPM_median":4.6,"TPM_75th_percentile":5.31,"TPM_max":6.02},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 122)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":122,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.39,"TPM_sd":7.94,"TPM_min":1.02,"TPM_25th_percentile":6.44,"TPM_median":9.22,"TPM_75th_percentile":13.47,"TPM_max":42.91},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 83)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":83,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.03,"TPM_sd":2.89,"TPM_min":2,"TPM_25th_percentile":6.14,"TPM_median":7.45,"TPM_75th_percentile":9.87,"TPM_max":15.22},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.21,"TPM_sd":2.68,"TPM_min":2.52,"TPM_25th_percentile":3.88,"TPM_median":5.24,"TPM_75th_percentile":6.56,"TPM_max":7.88},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":118,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.81,"TPM_sd":5.24,"TPM_min":3.38,"TPM_25th_percentile":7.88,"TPM_median":11.04,"TPM_75th_percentile":15.21,"TPM_max":32.68},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":21,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"Orphanet_2495","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.13,"TPM_sd":2.19,"TPM_min":0.18,"TPM_25th_percentile":4.21,"TPM_median":4.99,"TPM_75th_percentile":6.15,"TPM_max":10.17},{"x_label":"Metastatic secondary tumors  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Metastatic secondary tumors","GTEx_tissue_subgroup":"","EFO":"EFO_0009812","MONDO":"MONDO_0024883","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.03,"TPM_sd":1.5,"TPM_min":2.27,"TPM_25th_percentile":3.05,"TPM_median":4.16,"TPM_75th_percentile":5.14,"TPM_max":5.51},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 315)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":315,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":25.58,"TPM_sd":13.66,"TPM_min":2.32,"TPM_25th_percentile":15.02,"TPM_median":22.49,"TPM_75th_percentile":34.75,"TPM_max":69.06},{"x_label":"Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.84,"TPM_sd":3.28,"TPM_min":2.32,"TPM_25th_percentile":4.46,"TPM_median":4.8,"TPM_75th_percentile":6.56,"TPM_max":11.05},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":137,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.84,"TPM_sd":6.44,"TPM_min":3.32,"TPM_25th_percentile":11.29,"TPM_median":15.14,"TPM_75th_percentile":20.03,"TPM_max":32.96},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.57,"TPM_sd":1.86,"TPM_min":0.93,"TPM_25th_percentile":2.26,"TPM_median":3.08,"TPM_75th_percentile":4.36,"TPM_max":7.45},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.67,"TPM_sd":4.26,"TPM_min":4.13,"TPM_25th_percentile":5.31,"TPM_median":6.49,"TPM_75th_percentile":9.45,"TPM_max":12.4},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 128)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":128,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.15,"TPM_sd":3.39,"TPM_min":1.11,"TPM_25th_percentile":6.14,"TPM_median":7.85,"TPM_75th_percentile":9.4,"TPM_max":26.49},{"x_label":"Pleomorphic xanthoastrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 12)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Pleomorphic xanthoastrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016690","MONDO":"MONDO_0016690","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.6,"TPM_sd":2.26,"TPM_min":2.57,"TPM_25th_percentile":3.87,"TPM_median":5.3,"TPM_75th_percentile":6.68,"TPM_max":9.87},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.39,"TPM_sd":2.32,"TPM_min":2.16,"TPM_25th_percentile":4.27,"TPM_median":5.34,"TPM_75th_percentile":7.28,"TPM_max":7.88},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.46,"TPM_sd":3.06,"TPM_min":1.57,"TPM_25th_percentile":3.94,"TPM_median":5.98,"TPM_75th_percentile":8.54,"TPM_max":12.49},{"x_label":"Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 12)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Subependymal Giant Cell Astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016693","MONDO":"MONDO_0016693","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.89,"TPM_sd":0.65,"TPM_min":3.07,"TPM_25th_percentile":3.47,"TPM_median":3.78,"TPM_75th_percentile":4.24,"TPM_max":5.45},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.69,"TPM_sd":5.9,"TPM_min":1.84,"TPM_25th_percentile":2.75,"TPM_median":3.78,"TPM_75th_percentile":10.47,"TPM_max":15.64},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.29,"TPM_sd":6.71,"TPM_min":3.1,"TPM_25th_percentile":9.44,"TPM_median":13.39,"TPM_75th_percentile":17.5,"TPM_max":38.96},{"x_label":"All tissue subgroups  (Dataset = GTEx, Specimen = GTEx Normal Adult Tissues, N = 17382)","specimen_descriptor_fill":"GTEx Normal Adult Tissues","box_sample_count":17382,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"GTEx","Disease":"","GTEx_tissue_subgroup":"Adipose - Subcutaneous,Muscle - Skeletal,Artery - Tibial,Artery - Coronary,Heart - Atrial Appendage,Adipose - Visceral (Omentum),Uterus,Vagina,Breast - Mammary Tissue,Skin - Not Sun Exposed (Suprapubic),Minor Salivary Gland,Brain - Cortex,Adrenal Gland,Thyroid,Lung,Spleen,Pancreas,Esophagus - Muscularis,Esophagus - Mucosa,Esophagus - Gastroesophageal Junction,Stomach,Colon - Sigmoid,Small Intestine - Terminal Ileum,Colon - Transverse,Prostate,Testis,Nerve - Tibial,Skin - Sun Exposed (Lower leg),Heart - Left Ventricle,Brain - Cerebellum,Cells - Cultured fibroblasts,Blood,Artery - Aorta,Cells - EBV-transformed lymphocytes,Pituitary,Brain - Frontal Cortex (BA9),Brain - Caudate (basal ganglia),Brain - Nucleus accumbens (basal ganglia),Brain - Putamen (basal ganglia),Brain - Hypothalamus,Brain - Spinal cord (cervical c-1),Brain - Hippocampus,Brain - Anterior cingulate cortex (BA24),Ovary,Liver,Brain - Substantia nigra,Kidney - Cortex,Brain - Amygdala,Cervix - Ectocervix,Fallopian Tube,Cervix - Endocervix,Bladder,Kidney - Medulla","EFO":"","MONDO":"","GTEx_tissue_subgroup_UBERON":"UBERON_0002190,UBERON_0011907,UBERON_0007610,UBERON_0001621,UBERON_0006631,UBERON_0010414,UBERON_0000995,UBERON_0000996,UBERON_0008367,UBERON_0036149,UBERON_0006330,UBERON_0001870,UBERON_0002369,UBERON_0002046,UBERON_0008952,UBERON_0002106,UBERON_0001150,UBERON_0004648,UBERON_0006920,UBERON_0004550,UBERON_0000945,UBERON_0001159,UBERON_0001211,UBERON_0001157,UBERON_0002367,UBERON_0000473,UBERON_0001323,UBERON_0004264,UBERON_0006566,UBERON_0002037,UBERON_0013756,UBERON_0001496,UBERON_0000007,UBERON_0009834,UBERON_0001873,UBERON_0001882,UBERON_0001874,UBERON_0001898,UBERON_0006469,UBERON_0001954,UBERON_0009835,UBERON_0000992,UBERON_0001114,UBERON_0002038,UBERON_0001225,UBERON_0001876,UBERON_0012249,UBERON_0003889,UBERON_0000458,UBERON_0001255,UBERON_0001293","TPM_mean":11.35,"TPM_sd":6.03,"TPM_min":0.36,"TPM_25th_percentile":6.5,"TPM_median":11.01,"TPM_75th_percentile":15.19,"TPM_max":59.09}]